Zettinig G - Search Results

1

Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.

Zettinig G, Mitterhauser M, Wadsak W, Becherer A, Pirich C, Vierhapper H, Niederle B, Dudczak R, Kletter K. Zettinig G, et al. Eur J Nucl Med Mol Imaging. 2004 Sep;31(9):1224-30. doi: 10.1007/s00259-004-1575-0. Epub 2004 Jun 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 15197504 Clinical Trial.

2

FDG positron emission tomography in patients with systemic mastocytosis.

Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P, Kletter K. Zettinig G, et al. AJR Am J Roentgenol. 2002 Nov;179(5):1235-7. doi: 10.2214/ajr.179.5.1791235. AJR Am J Roentgenol. 2002. PMID: 12388504

3

Comparison of three different purification methods for the routine preparation of [11C] Metomidate.

Mitterhauser M, Wadsak W, Langer O, Schmaljohann J, Zettinig G, Dudczak R, Viernstein H, Kletter K. Mitterhauser M, et al. Among authors: zettinig g. Appl Radiat Isot. 2003 Aug-Sep;59(2-3):125-8. doi: 10.1016/s0969-8043(03)00168-4. Appl Radiat Isot. 2003. PMID: 12941500

4

Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine.

Becherer A, Karanikas G, Szabó M, Zettinig G, Asenbaum S, Marosi C, Henk C, Wunderbaldinger P, Czech T, Wadsak W, Kletter K. Becherer A, et al. Among authors: zettinig g. Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1561-7. doi: 10.1007/s00259-003-1259-1. Epub 2003 Jul 23. Eur J Nucl Med Mol Imaging. 2003. PMID: 14579097 Clinical Trial.

5

Imaging of adrenocortical metastases with [11C]metomidate.

Mitterhauser M, Dobrozemsky G, Zettinig G, Wadsak W, Vierhapper H, Dudczak R, Kletter K. Mitterhauser M, et al. Among authors: zettinig g. Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):974. doi: 10.1007/s00259-006-0103-9. Epub 2006 May 24. Eur J Nucl Med Mol Imaging. 2006. PMID: 16721573 No abstract available.

6

FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma.

Zettinig G, Leitha T, Niederle B, Kaserer K, Becherer A, Kletter K, Dudczak R. Zettinig G, et al. Clin Nucl Med. 2001 Jul;26(7):599-601. doi: 10.1097/00003072-200107000-00003. Clin Nucl Med. 2001. PMID: 11416738

7

Imaging of aortic prosthesis infection with a combined SPET/CT device.

Hofmann A, Zettinig G, Wachter S, Kurtaran A, Kainberger F, Dudczak R. Hofmann A, et al. Among authors: zettinig g. Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):836. doi: 10.1007/s00259-002-0860-z. Epub 2002 Apr 30. Eur J Nucl Med Mol Imaging. 2002. PMID: 12029563 No abstract available.

8

Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study.

Zettinig G, Hanselmayer G, Fueger BJ, Hofmann A, Pirich C, Nepp J, Dudczak R. Zettinig G, et al. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1428-32. doi: 10.1007/s00259-002-0969-0. Epub 2002 Aug 28. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397459 Clinical Trial.

9

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma.

Hoffmann M, Vogelsang H, Kletter K, Zettinig G, Chott A, Raderer M. Hoffmann M, et al. Among authors: zettinig g. Gut. 2003 Mar;52(3):347-51. doi: 10.1136/gut.52.3.347. Gut. 2003. PMID: 12584214 Free PMC article.

10

Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy?

Zettinig G, Fueger BJ, Passler C, Kaserer K, Pirich C, Dudczak R, Niederle B. Zettinig G, et al. Clin Endocrinol (Oxf). 2002 Mar;56(3):377-82. doi: 10.1046/j.1365-2265.2002.01482.x. Clin Endocrinol (Oxf). 2002. PMID: 11940050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page